Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients

NCT01813500 is registered in ClinicalTrials.gov with Boston Medical Center as lead sponsor.

NCT NCT01813500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01813500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
Lead sponsor
Boston Medical Center
Phase
Observational
Overall status
Completed
Start date
October 31, 2011
Completion date
April 30, 2016
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile, crohn's disease, inflammatory bowel disease, ulcerative colitis